Mylan N.V. (NASDAQ:MYL) to Release Quarterly Earnings on Wednesday
Mylan N.V. (NASDAQ:MYL) will announce its earnings results before the market opens on Wednesday, August 9th. Analysts expect the company to announce earnings of $1.19 per share for the quarter.
Mylan N.V. (NASDAQ:MYL) last posted its quarterly earnings data on Wednesday, May 10th. The company reported $0.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.92 by $0.01. Mylan N.V. had a return on equity of 23.69% and a net margin of 4.59%. The firm had revenue of $2.72 billion during the quarter, compared to analysts’ expectations of $2.81 billion. During the same period in the prior year, the business earned $0.76 EPS. The company’s revenue for the quarter was up 24.1% compared to the same quarter last year. On average, analysts expect Mylan N.V. to post $5.16 EPS for the current fiscal year and $5.67 EPS for the next fiscal year.
Mylan N.V. (MYL) opened at 32.00 on Tuesday. The stock has a 50 day moving average price of $38.42 and a 200-day moving average price of $39.28. Mylan N.V. has a 12-month low of $31.47 and a 12-month high of $50.40. The stock has a market capitalization of $17.15 billion, a PE ratio of 31.97 and a beta of 1.27.
In other Mylan N.V. news, insider Anthony Mauro sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of $40.00, for a total transaction of $400,000.00. Following the completion of the transaction, the insider now owns 140,653 shares in the company, valued at $5,626,120. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, President Rajiv Malik sold 25,000 shares of the business’s stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $1,000,000.00. Following the transaction, the president now owns 799,855 shares of the company’s stock, valued at approximately $31,994,200. The disclosure for this sale can be found here. 0.69% of the stock is owned by insiders.
A number of research analysts have recently weighed in on MYL shares. Barclays PLC upgraded Mylan N.V. from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $47.00 to $50.00 in a research report on Monday, May 22nd. Royal Bank Of Canada restated a “sector perform” rating and set a $46.00 price objective (down previously from $48.00) on shares of Mylan N.V. in a research report on Monday, April 17th. BMO Capital Markets started coverage on Mylan N.V. in a research report on Monday, May 1st. They set an “outperform” rating and a $50.00 price objective for the company. Wells Fargo & Company restated a “market perform” rating and set a $40.00 price objective on shares of Mylan N.V. in a research report on Friday, April 14th. Finally, Cantor Fitzgerald started coverage on Mylan N.V. in a research report on Friday, June 16th. They set a “neutral” rating and a $41.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $50.21.
ILLEGAL ACTIVITY NOTICE: This article was originally published by Daily Political and is the property of of Daily Political. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/08/08/mylan-n-v-nasdaqmyl-to-release-quarterly-earnings-on-wednesday.html.
About Mylan N.V.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.